Twist Bioscience Announces The Expansion Of Its DNA Synthesis Offering With The Launch Of Gene Fragments With Increased Lengths Ranging From 1.8kb To 5.0kb
Portfolio Pulse from Benzinga Newsdesk
Twist Bioscience Corporation (NASDAQ:TWST) has expanded its DNA synthesis offering by launching Gene Fragments with increased lengths ranging from 1.8kb to 5.0kb. These new products are available through Twist's ecommerce platform and maintain the same speed, quality, and affordability as shorter fragments, with a turnaround time starting at two business days.
August 08, 2024 | 12:37 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Twist Bioscience has launched new Gene Fragments with lengths up to 5.0kb, enhancing its DNA synthesis product line. This expansion is expected to attract more customers due to the increased versatility and maintained quality, potentially boosting short-term stock prices.
The launch of longer Gene Fragments enhances Twist Bioscience's product offering, making it more attractive to customers needing longer DNA sequences. This could lead to increased sales and revenue, positively impacting the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100